Alto Ingredients financials
$3.63−1.09%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $245.7M | $224.7M | $232.0M | $241.0M | $218.4M | $226.5M | $236.3M | $251.8M | $236.5M | $240.6M | $273.6M | $318.1M |
| Gross profit | $16.6M | $9.2M | $15.2M | $23.5M | -$1.9M | -$1.8M | -$1.4M | $6.0M | $7.6M | -$2.4M | -$2.5M | $4.2M |
| Gross margin | 6.8% | 4.1% | 6.5% | 9.7% | −0.9% | −0.8% | −0.6% | 2.4% | 3.2% | −1.0% | −0.9% | 1.3% |
| Operating income | $8.6M | $2.5M | $7.5M | $17.0M | -$8.1M | -$9.0M | -$39.2M | -$1.6M | -$1.4M | -$10.3M | -$16.9M | -$4.3M |
| Net income | $11.4M | $4.0M | $21.5M | $13.9M | -$11.3M | -$12.0M | -$42.0M | -$2.8M | -$3.4M | -$12.0M | -$19.3M | -$3.8M |
| Net margin | 4.6% | 1.8% | 9.3% | 5.8% | −5.2% | −5.3% | −17.8% | −1.1% | −1.4% | −5.0% | −7.0% | −1.2% |
| Diluted EPS | $0.15 | $0.05 | $0.27 | $0.19 | $-0.15 | $-0.16 | $-0.57 | $-0.04 | $-0.05 | $-0.17 | $-0.27 | $-0.05 |
| EBITDA | $15.3M | $9.1M | $14.4M | $23.5M | -$1.5M | -$2.5M | $79.0K | $4.8M | $4.9M | -$4.4M | -$8.1M | $1.6M |
| Operating cash flow | $28.5M | $4.2M | $9.5M | $22.8M | -$848.0K | -$18.2M | -$9.8M | $18.6M | -$13.7M | $1.4M | $15.3M | $19.6M |
| Free cash flow | $17.9M | $3.3M | $7.6M | $21.2M | -$1.3M | -$18.8M | -$11.1M | $18.1M | -$18.4M | -$3.2M | $10.4M | $13.0M |
| Diluted shares | 77.1M | 74.8M | 79.4M | 74.8M | 74.6M | 73.8M | 73.8M | 73.8M | 73.5M | 72.8M | 72.2M | 73.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $24.0M | $20.3M | $23.4M | $32.5M | $29.8M | $26.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $60.5M | $73.1M | $79.6M | $100.6M | $118.3M | $110.7M |
| Total assets | $397.1M | $386.3M | $388.8M | $388.5M | $393.1M | $402.2M |
| Total liabilities | $137.2M | $136.4M | $143.5M | $166.1M | $185.2M | $188.3M |
| Shareholders' equity | $259.9M | $249.9M | $245.2M | $222.4M | $207.8M | $213.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology